Feasibility of ambulatory blood pressure measurement using smartwatch in patients with Parkinson’s disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005985

Enrollment

Registered

2021-03-10

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Measure the blood pressure at 30 minutes intervals while awake for 24 hours using the Smartwatch (SM-R850) and the standard instrument (TONOPORTV).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Idiopathic Parkinson’s disease based on International Parkinson’s disease and Movement Disorders Society criteria 2. normal cognition (MMSE = 26)

Exclusion criteria

Exclusion criteria: Patients with 1. Unable to measure of blood pressure because of arrhythmia, cardiovascular disease 2. Unable to measure of blood pressure because of musculoskeletal disease 3. atypical parkinsonism 4. Patients with a difference of 10 mmHg or more in systolic blood pressure between upper arms 5. Other patients who deemed inappropriate for the study by the researcher

Design outcomes

Primary

Measure	Time frame
Feasibility of blood pressure measured by smartwatch	—

Secondary

Measure	Time frame
Agreement between the BP measure by smartwatch and reference device	—

Countries

Korea, Republic of

Contacts

Public ContactAhn Jong Hyeon

Samsung Medical Center

Outcome results